Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | PPM1B | O75688 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16121021 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TP53CYP3A4CHRM2CHRM4 | |
| SCHEMBL1296512 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TP53CYP3A4CHRM2CHRM4 | |
| SCHEMBL16121103 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TP53CYP3A4CHRM2CHRM4 | |
| SCHEMBL8245720 | 0.97 | ALDH1A1 (0.42) | ALDH1A1TP53CYP3A4CHRM2CHRM4 | |
| Ethylene Glycol SCHEMBL9893783 | 0.95 | TP53 (0.39) | ALDH1A1TP53CYP3A4CHRM2CHRM4 | |
| Ethylene Glycol SCHEMBL1295943 | 0.95 | TP53 (0.39) | ALDH1A1TP53CYP3A4CHRM2CHRM4 | |
| Ethylene Glycol SCHEMBL9894028 | 0.95 | TP53 (0.39) | ALDH1A1TP53CYP3A4CHRM2CHRM4 | |
| SCHEMBL1296978 | 0.95 | PPARG (0.43) | TP53CYP3A4CHRM2CHRM4CHRM5 | |
| SCHEMBL5512030 | 0.93 | PPARG (0.46) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL1296642 | 0.93 | PPARG (0.46) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12619006-B2 | Wavelength selective absorption filter and display device | FUJIFILM CORPORATION (JP) | 2026-05-05 | — | — | US | disclosed |
| US-20230288610-A1 | WAVELENGTH SELECTIVE ABSORPTION FILTER AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| US-9102660-B2 | Process of making prostacyclin compounds with linker thiol and pegylated forms | United Therapeutics Corporaiton (US) | 2015-08-11 | — | — | US | disclosed |
| US-20140288314-A1 | PROCESS OF MAKING PROSTACYCLIN COMPOUNDS WITH LINKER THIOL AND PEGYLATED FORMS | UNITED THERAPEUTICS CORPORATION (US) | 2014-09-25 | — | — | US | disclosed |
| US-20070059458-A1 | Cellulose acylate film, optically compensatory film, polarizing plate and liquid crystal display | FUJI PHOTO FILM CO., LTD. (JP) | 2007-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12619006-B2 | Wavelength selective absorption filter and display device | STRA6, SULT1A1, SLC7A1 | ALDH1A1 38/4885TP53 4273/4885CYP3A4 728/4885 |
| US-20140288314-A1 | PROCESS OF MAKING PROSTACYCLIN COMPOUNDS WITH LINKER THIOL AND PEGYLATED FORMS | PTGIS, PTGIR, PTGER1 | ALDH1A1 413/4885TP53 4600/4885CYP3A4 137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.